Stryker (NYSE: SYK) recently appointed Jessica Mathieson to the role of president of Medical, a key part of its MedSurg and Neurotechnology business. Mathieson has been with Stryker since November 2008, starting as an account manager and progressing through various roles of increasing responsibility, including serving as VP and GM of the Acute Care division.
Stryker’s Medical division is a critical component of the company’s MedSurg and Neurotechnology business, generating the highest revenue within the business’s four segments in 2022. The division offers a range of products, including patient handling equipment, emergency medical supplies, disposable products for intensive care, and clinical communication and workflow services.
Andy Pierce, Stryker’s president of MedSurg and Neurotechnology, praised Mathieson for her leadership and dedication to the company’s culture and inclusive environment. He highlighted her track record of delivering exceptional results that have led to significant growth and global expansion for her teams.
Pierce expressed his excitement about Mathieson’s new role in shaping the strategy for Medical. He emphasized the importance of partnering with customers to improve outcomes and drive success in this critical business unit. Mathieson’s promotion reflects Stryker’s commitment to recognizing and empowering talented leaders within the organization.
In conclusion, Stryker’s recent appointment of Jessica Mathieson as president of Medical is an exciting development for both the company and its customers. With a proven track record of delivering exceptional results, Mathieson’s leadership will undoubtedly play a critical role in shaping the future success of this key business unit at Stryker.